Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 10/27 11:55:00 am
431.95 DKK   -1.59%
10:15aNOVO NORDISK A/S : quaterly earnings release
10/26NOVO NORDISK A/S : – Share repurchase programme
AQ
10/16NOVO NORDISK : Buy rating from Goldman Sachs
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Analysis
New $1 billion fund aims to steer antibiotic companies in tough market
More Must read
Stock Pick
Novo Nordisk AS : Global leader in diabetes treatments
Novo Nordisk is the world leader in diabetes treatments and a long-standing rival of Sanofi. The company has successfully negotiated the repositioning of its portfolio.
More Recommendations
Official Publications
08/06Half-year results 
08/05Share buyback 
07/28Share buyback 
07/20Share buyback 
07/13Share buyback 
07/06Share buyback 
Upcoming event on NOVO NORDISK A/S
10/30/20Q3 2020 Earnings Call
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers Offre Binck Best of des tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2020 Surperformance. All rights reserved. Les cotations sont fournies par Factset, Morningstar,S&P Capital IQ et vwd Group